The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx).
L. A. Herran
No relevant relationships to disclose
K. L. Jhaveri
No relevant relationships to disclose
A. D. Seidman
No relevant relationships to disclose
D. Patel
No relevant relationships to disclose
A. N. Gewirtz
No relevant relationships to disclose
N. E. Kemeny
No relevant relationships to disclose